was read the article
array:21 [ "pii" => "X2013251407021578" "issn" => "20132514" "doi" => " " "estado" => "S300" "fechaPublicacion" => "2007-08-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2007;27:466-71" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2821 "formatos" => array:3 [ "EPUB" => 216 "HTML" => 1986 "PDF" => 619 ] ] "Traduccion" => array:1 [ "es" => array:17 [ "pii" => "X0211699507021570" "issn" => "02116995" "doi" => " " "estado" => "S300" "fechaPublicacion" => "2007-08-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia. 2007;27:466-71" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 9812 "formatos" => array:3 [ "EPUB" => 295 "HTML" => 8850 "PDF" => 667 ] ] "es" => array:11 [ "idiomaDefecto" => true "titulo" => "Carbonato cálcico o sevelamer reducen la excreción urinaria de oxalato en pacientes con insuficiencia renal avanzada" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "466" "paginaFinal" => "471" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Either calcium carbonate or sevelamer decreases urinary oxalate excretion in chronic renal failure patients" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Francisco Caravaca, Ana Belén Ruiz, Jose María Escola, Román Hernández-Gallego, Isis Cerezo, Noemí Fernández, Sergio Barroso, María Vic" "autores" => array:1 [ 0 => array:1 [ "nombre" => "Francisco Caravaca, Ana Belén Ruiz, Jose María Escola, Román Hernández-Gallego, Isis Cerezo, Noemí Fernández, Sergio Barroso, María Vic" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "X2013251407021578" "doi" => " " "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251407021578?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699507021570?idApp=UINPBA000064" "url" => "/02116995/0000002700000004/v0_201502091325/X0211699507021570/v0_201502091325/es/main.assets" ] ] "itemSiguiente" => array:17 [ "pii" => "X201325140702156X" "issn" => "20132514" "doi" => " " "estado" => "S300" "fechaPublicacion" => "2007-08-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2007;27:472-81" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 3284 "formatos" => array:3 [ "EPUB" => 275 "HTML" => 2248 "PDF" => 761 ] ] "en" => array:10 [ "idiomaDefecto" => true "titulo" => "Preliminary study on efficacy and tolerance of a «coupage» of olive oil in patients with chronic kidney disease. Nutritonal evalution" "tienePdf" => "en" "tieneTextoCompleto" => 0 "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "472" "paginaFinal" => "481" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Estudio preliminar sobre eficacia y tolerancia de un «coupage» de aceite de oliva en pacientes con enfermedad renal crónica. Evaluación del estado de nutrición" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Vicente Pérez-Bañasco, Jose Manuel Gil-Cunquero, Francisco José Borrego-Utiel, Manuela Gassó, Pilar Segura-Torres, Fernando Warletta, J.L." "autores" => array:1 [ 0 => array:1 [ "nombre" => "Vicente Pérez-Bañasco, Jose Manuel Gil-Cunquero, Francisco José Borrego-Utiel, Manuela Gassó, Pilar Segura-Torres, Fernando Warletta, J.L." ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "X0211699507021562" "doi" => " " "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699507021562?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X201325140702156X?idApp=UINPBA000064" "url" => "/20132514/0000002700000004/v0_201502091551/X201325140702156X/v0_201502091551/en/main.assets" ] "itemAnterior" => array:17 [ "pii" => "X2013251407021586" "issn" => "20132514" "doi" => " " "estado" => "S300" "fechaPublicacion" => "2007-08-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2007;27:459-65" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2888 "formatos" => array:3 [ "EPUB" => 201 "HTML" => 2031 "PDF" => 656 ] ] "en" => array:10 [ "idiomaDefecto" => true "titulo" => "Mycophenolate mofetil in the treatment of lupus nephritis, in patients with failure, intolerance or relapses after treatment with steroids and cyclophosphamide" "tienePdf" => "en" "tieneTextoCompleto" => 0 "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "459" "paginaFinal" => "465" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Micofenolato mofetil en el tratamiento de la nefritis lúpica en pacientes con fracaso, intolerancia o recidivas tras tratamiento con esteroides y ciclofosfamida" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Santiago Suria González Nefrología Hospital Universitario Insular de Gran Canaria, María Dolores Checa Andrés Nefrología Hospital Universitario Insu" "autores" => array:1 [ 0 => array:1 [ "nombre" => "Santiago Suria González Nefrología Hospital Universitario Insular de Gran Canaria, María Dolores Checa Andrés Nefrología Hospital Universitario Insu" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "X0211699507021589" "doi" => " " "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699507021589?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251407021586?idApp=UINPBA000064" "url" => "/20132514/0000002700000004/v0_201502091551/X2013251407021586/v0_201502091551/en/main.assets" ] "en" => array:11 [ "idiomaDefecto" => true "titulo" => "Either calcium carbonate or sevelamer decreases urinary oxalate excretion in chronic renal failure patients" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "466" "paginaFinal" => "471" ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Francisco Caravaca, Ana Belén Ruiz, Jose María Escola, Román Hernández-Gallego, Isis Cerezo, Noemí Fernández, Sergio Barroso, María Vic" "autores" => array:1 [ 0 => array:1 [ "nombre" => "Francisco Caravaca, Ana Belén Ruiz, Jose María Escola, Román Hernández-Gallego, Isis Cerezo, Noemí Fernández, Sergio Barroso, María Vic" ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Carbonato cálcico o sevelamer reducen la excreción urinaria de oxalato en pacientes con insuficiencia renal avanzada" ] ] "pdfFichero" => "P-E-S-A4616-EN.pdf" "tienePdf" => true "PalabrasClave" => array:2 [ "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec436245" "palabras" => array:1 [ 0 => "Carbonato cálcico, insuficiencia renal crónica, oxalato, sevelamer" ] ] ] "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec436246" "palabras" => array:1 [ 0 => "Calcium carbonate, chronic renal failure, oxalate, sevelamer" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:1 [ "resumen" => "The rate of oxalate absorbed from intestine is highly influenced by calcium intake in healthy subjects. It is unknown whether commonly used phosphate binders modify intestinal absorption and renal excretion of oxalate in chronic kidney disease (CKD) patients. This study aims to determine if calcium carbonate or sevelamer influences on urinary oxalate excretion. Twenty patients with CKD (stage 4 and 5 pre-dialysis) were included. Two treatment (1500 mg of calcium carbonate or 2400 mg of sevelamer), two-period (21 days each), crossover study with balanced assignment of the order of administration, and two washout periods were the main characteristics of this study design. Laboratory analyses in each phase included: serum creatinine, calcium, phosphorus, bicarbonate, total cholesterol, and 24 h urinary excretion of oxalate, creatinine, and urea. Creatinine clearance, protein catabolic rate (PNNA), total urinary oxalate excretion, and urinary oxalate / creatinine ratio were determined. Seventeen patients completed both treatment sequences. Total urinary oxalate excretion and urinary oxalate / creatinine ratios decreased significantly with respect to washout periods either after sevelamer or calcium carbonate treatment. The decrease in urinary oxalate excretion was greater after calcium carbonate (41.2±17.4%) than after sevelamer treatment (30.4±23.8%). There were not significant changes in renal function or PNNA values throughout the study periods. In conclusion, either calcium carbonate or sevelamer significantly reduces urinary oxalate excretion in CKD patients. Further studies will be needed to ascertain whether the type of phosphate binder influences on the accumulation of oxalate in CKD patients. " ] "es" => array:1 [ "resumen" => "El ácido oxálico (Ox) es una reconocida tóxina urémica. La cantidad de calcio en la dieta influye en la absorción intestinal de Ox en los sujetos sanos. Se desconoce si los quelantes de fósforo que contienen calcio o los nuevos quelantes sin calcio modifican la absorción o excreción de Ox en la enfermedad renal crónica (ERC). El objetivo de este estudio fue determinar si el carbonato cálcico (CC) o el sevelamer (S) modifican la excreción urinaria de oxalato en pacientes con ERC. Se incluyeron 20 pacientes con ERC estadios 4-5 pre-diálisis sin historia previa de litiasis o enfermedades digestivas. Tras un periodo de lavado sin quelantes se asignó a cada mitad del grupo la administración de CC 1500 mg ó S 2400 mg durante 21 días. Tras otro nuevo periodo de lavado (15 días), cada paciente recibió el tratamiento contrario durante otros 21 días. En cada fase del estudio se determinaron los siguientes parámetros séricos: creatinina, calcio, fósforo, bicarbonato, colesterol total. En orina recogida durante 24 horas se midió Ox, creatinina y urea, determinando la excreción total de oxalato, cociente Ox/creatinina, aclaramiento creatinina y tasa de catabolismo proteico. Diecisiete pacientes completaron el estudio. La administración tanto de CC como de S redujeron significativamente la excreción total de Ox y el cociente Ox / creatinina con respecto a las concentraciones en fases de lavado. La reducción de oxalato en orina fue mayor tras CC (41.2±17.4%) que tras S (30.4±23.8%), aunque estas diferencias entre quelantes no fueron estadísticamente significativas. El resto de los cambios bioquímicos observados fueron los esperables para cada uno de estos quelantes, sin que se observaran diferencias significativas ni en la función renal ni en la tasa de catabolismo proteico. En conclusión, tanto el CC como el S reducen la excreción urinaria de Ox en pacientes con ERC. Estos cambios son probablemente el reflejo de una menor absorción intestinal de Ox. El tipo de quelante de fósforo podría influir en la cantidad de Ox acumulado a lo largo de la evolución de la ERC. " ] ] ] "idiomaDefecto" => "en" "url" => "/20132514/0000002700000004/v0_201502091551/X2013251407021578/v0_201502091551/en/main.assets" "Apartado" => null "PDF" => "https://static.elsevier.es/multimedia/20132514/0000002700000004/v0_201502091551/X2013251407021578/v0_201502091551/en/P-E-S-A4616-EN.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251407021578?idApp=UINPBA000064" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 6 | 11 | 17 |
2024 October | 50 | 65 | 115 |
2024 September | 50 | 81 | 131 |
2024 August | 56 | 89 | 145 |
2024 July | 46 | 55 | 101 |
2024 June | 64 | 83 | 147 |
2024 May | 85 | 57 | 142 |
2024 April | 58 | 50 | 108 |
2024 March | 50 | 39 | 89 |
2024 February | 47 | 36 | 83 |
2024 January | 43 | 110 | 153 |
2023 December | 30 | 34 | 64 |
2023 November | 54 | 51 | 105 |
2023 October | 39 | 69 | 108 |
2023 September | 64 | 119 | 183 |
2023 August | 74 | 34 | 108 |
2023 July | 34 | 51 | 85 |
2023 June | 76 | 37 | 113 |
2023 May | 111 | 53 | 164 |
2023 April | 102 | 48 | 150 |
2023 March | 72 | 20 | 92 |
2023 February | 25 | 37 | 62 |
2023 January | 25 | 41 | 66 |
2022 December | 45 | 31 | 76 |
2022 November | 29 | 40 | 69 |
2022 October | 34 | 51 | 85 |
2022 September | 36 | 46 | 82 |
2022 August | 31 | 31 | 62 |
2022 July | 28 | 47 | 75 |
2022 June | 43 | 34 | 77 |
2022 May | 25 | 36 | 61 |
2022 April | 24 | 41 | 65 |
2022 March | 40 | 56 | 96 |
2022 February | 31 | 36 | 67 |
2022 January | 28 | 38 | 66 |
2021 December | 31 | 40 | 71 |
2021 November | 35 | 42 | 77 |
2021 October | 37 | 50 | 87 |
2021 September | 24 | 29 | 53 |
2021 August | 25 | 30 | 55 |
2021 July | 30 | 33 | 63 |
2021 June | 24 | 16 | 40 |
2021 May | 30 | 25 | 55 |
2021 April | 54 | 62 | 116 |
2021 March | 43 | 17 | 60 |
2021 February | 25 | 30 | 55 |
2021 January | 24 | 17 | 41 |
2020 December | 20 | 21 | 41 |
2020 November | 19 | 12 | 31 |
2020 October | 16 | 18 | 34 |
2020 September | 19 | 14 | 33 |
2020 August | 31 | 13 | 44 |
2020 July | 21 | 20 | 41 |
2020 June | 16 | 18 | 34 |
2020 May | 24 | 16 | 40 |
2020 April | 20 | 26 | 46 |
2020 March | 19 | 22 | 41 |
2020 February | 24 | 18 | 42 |
2020 January | 31 | 41 | 72 |
2019 December | 24 | 34 | 58 |
2019 November | 20 | 29 | 49 |
2019 October | 7 | 21 | 28 |
2019 September | 11 | 29 | 40 |
2019 August | 10 | 14 | 24 |
2019 July | 10 | 20 | 30 |
2019 June | 16 | 14 | 30 |
2019 May | 14 | 27 | 41 |
2019 April | 40 | 27 | 67 |
2019 March | 15 | 15 | 30 |
2019 February | 4 | 9 | 13 |
2019 January | 10 | 19 | 29 |
2018 December | 22 | 17 | 39 |
2018 November | 23 | 12 | 35 |
2018 October | 22 | 16 | 38 |
2018 September | 21 | 12 | 33 |
2018 August | 22 | 14 | 36 |
2018 July | 11 | 19 | 30 |
2018 June | 15 | 14 | 29 |
2018 May | 24 | 18 | 42 |
2018 April | 10 | 10 | 20 |
2018 March | 20 | 13 | 33 |
2018 February | 10 | 9 | 19 |
2018 January | 6 | 5 | 11 |
2017 December | 15 | 11 | 26 |
2017 November | 12 | 6 | 18 |
2017 October | 9 | 8 | 17 |
2017 September | 11 | 7 | 18 |
2017 August | 10 | 13 | 23 |
2017 July | 16 | 9 | 25 |
2017 June | 8 | 8 | 16 |
2017 May | 8 | 11 | 19 |
2017 April | 8 | 7 | 15 |
2017 March | 11 | 13 | 24 |
2017 February | 10 | 7 | 17 |
2017 January | 15 | 6 | 21 |
2016 December | 33 | 12 | 45 |
2016 November | 40 | 5 | 45 |
2016 October | 42 | 10 | 52 |
2016 September | 63 | 10 | 73 |
2016 August | 91 | 5 | 96 |
2016 July | 110 | 4 | 114 |
2016 June | 82 | 0 | 82 |
2016 May | 114 | 0 | 114 |
2016 April | 66 | 0 | 66 |
2016 March | 76 | 0 | 76 |
2016 February | 84 | 0 | 84 |
2016 January | 69 | 0 | 69 |
2015 December | 102 | 0 | 102 |
2015 November | 88 | 0 | 88 |
2015 October | 82 | 0 | 82 |
2015 September | 65 | 0 | 65 |
2015 August | 60 | 0 | 60 |
2015 July | 53 | 0 | 53 |
2015 June | 41 | 0 | 41 |
2015 May | 49 | 0 | 49 |
2015 April | 16 | 0 | 16 |